Home > Insider Trading > Filing (0001567619-22-021651)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1626971	Corvus Pharmaceuticals Inc.	CRVS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
939012	Leiv Lea	C/O Corvus Pharmaceuticals, Inc. 863 Mitten Road, Suite 102 Burlingame CA 94010	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-13	30,000	$0.74	129,238	No	4	P	Indirect	By IRA
Common Stock	Acquisiton	2022-12-14	4,000	$0.84	133,238	No	4	P	Indirect	By IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By IRA
No	4	P	Indirect	By IRA

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	149,206	Indirect	By Trust

Footnotes

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7255 to $0.7806, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
These shares are held by Leiv Lea IRA Contributory.
These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.